Cisplatin-based chronotherapy for advanced non-small cell lung cancer patients: a randomized controlled study and its pharmacokinetics analysis. (Q52935869)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 June 2015

Language	Label	Description	Also known as
English	Cisplatin-based chronotherapy for advanced non-small cell lung cancer patients: a randomized controlled study and its pharmacokinetics analysis.	scientific article published on 21 June 2015

Statements

scholarly article

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/26093951

Cisplatin-based chronotherapy for advanced non-small cell lung cancer patients: a randomized controlled study and its pharmacokinetics analysis. (English)

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/26093951

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Jie Li

1

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/26093951

Rong Chen

2

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/26093951

Mei Ji

3

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/26093951

Su-Lan Zou

4

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/26093951

Li-Na Zhu

5

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/26093951

publication date

21 June 2015

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/26093951

number of pages

5

1 reference

based on heuristic

inferred from page(s)

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/26093951

76

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/26093951

651-655

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/26093951

3

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/26093951

https://scigraph.springernature.com/pub.10.1007/s00280-015-2804-x

0 references

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2804-X

21 January 2018

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2804-X

21 January 2018

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2804-X

21 January 2018

Chronotherapeutics: the relevance of timing in cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2804-X

21 January 2018

Pharmacokinetic analysis of capecitabine and cisplatin in combination with trastuzumab in Japanese patients with advanced HER2-positive gastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2804-X

21 January 2018

Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2804-X

21 January 2018

Population pharmacokinetics of cisplatin in adult cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2804-X

21 January 2018

Population pharmacokinetics of platinum after nedaplatin administration and model validation in adult patients

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2804-X

21 January 2018

Population pharmacokinetics of total and unbound plasma cisplatin in adult patients

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2804-X

21 January 2018

Circadian variability of pharmacokinetics of cisplatin in patients with non-small-cell lung carcinoma: analysis with the NONMEM program.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2804-X

21 January 2018

Chronotherapy and the molecular clock: Clinical implications in oncology.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2804-X

21 January 2018

The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2804-X

21 January 2018

The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2804-X

21 January 2018

The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2804-X

21 January 2018

Time-patterned drug administration: insights from a modeling approach

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2804-X

21 January 2018

Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2804-X

21 January 2018

Identifiers

10.1007/S00280-015-2804-X

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/26093951

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/26093951

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52935869&oldid=2143784590"